Trial · NCT02700685
Registered outcomes28
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 28
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Summed ADHD score of the ADHD-Rating Scale as rated by teachers | 10 weeks | |
| Secondary | Summed ADHD score of the ADHD-Rating Scale as rated by teachers | 5 weeks | |
| Secondary | Summed ADHD score of the ADHD-Rating Scale as rated by parents | 5 weeks, 10 weeks | |
| Secondary | Summed ADHD score of the Social-Emotional Questionnaire (SEQ) as rated by parents and teachers | 10 weeks | |
| Secondary | Scores on ADHD subscales of the ADHD-RS as rated by parents and teachers - hyperactivity, impulsivity and inattention | 5 & 10 weeks | |
| Secondary | Scores on ADHD subscales of the SEQ as rated by parents and teachers - hyperactivity, impulsivity and inattention | 5 & 10 weeks | |
| Secondary | Percentage of responders (ADHD-RS) as rated by parents and teachers | 5 & 10 weeks | Score reduction of at least 20% for parents and/or teachers |
| Secondary | Percentage of responders (SEQ) as rated by parents and teachers | 5 & 10 weeks | Score reduction of at least 20% for parents and/or teachers |
| Secondary | Social behavior problems subscale of the SEQ, as rated by parents and teachers | 10 weeks | |
| Secondary | Anxiety subscale of the SEQ, as rated by parents and teachers | 10 weeks | |
| Secondary | Physical and sleep complaints score as measured by the Physical Complaints Questionnaire (PCQ) | 5 & 10 weeks | |
| Secondary | Erythrocyte glutathione (GSH) level | 10 weeks | |
| Secondary | Urinary 8-OHdG level | 10 weeks | |
| Secondary | Plasma cytokine levels | 10 weeks | |
| Secondary | Plasma antibody levels | 10 weeks | |
| Secondary | Gene expression | 10 weeks | |
| Secondary | Serum neuropeptide Y | 10 weeks | |
| Secondary | Serum zinc | 10 weeks | |
| Secondary | Intestinal microbial composition | 10 weeks | |
| Secondary | Intervention acceptability | 10 weeks | Percentage of participants with side effects, treatment adherence and proportion of drop-outs |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02700685/registered